Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy
Xiaoxue Xie(China Pharmaceutical University), Hong Yang(University of Electronic Science and Technology of China), Qingqing Su(University of Electronic Science and Technology of China), Yiyao Liu(University of Electronic Science and Technology of China), Guixue Wang(Chongqing University), Ningxi Li(University of Electronic Science and Technology of China), Xiaodan Wei(Sanofi (United States)), Hanxi Zhang(Nanjing Drum Tower Hospital), Tingting Li(Sichuan University), Shun Li(University of Electronic Science and Technology of China), Xiaojuan Zhang(University of Colorado Boulder), Geng Yang(University of Electronic Science and Technology of China), Chunhui Wu(University of Electronic Science and Technology of China), Yi Feng(Army Medical University), Ting Song(University of Electronic Science and Technology of China), Xiang Qin(University of Electronic Science and Technology of China)
Cited by 53
Related Papers
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Silicon Oxycarbide Glasses
|Journal of Sol-Gel Science and Technology|1999|404
Synthesis and Characterization of Silicon Oxycarbide Glasses
|Journal of the American Ceramic Society|1990|235
Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer
|Acta Biomaterialia|2019|223